Survodutide

🔹 What is Survodutide?

Class: Synthetic 29-amino acid peptide; dual agonist of glucagon and GLP-1 receptors. Mechanism:

• Activates glucagon receptor (GCGR) to enhance lipid oxidation and energy expenditure.
• Stimulates GLP-1 receptor (GLP-1R) to promote satiety, insulin secretion, and glucose homeostasis.
• Dual receptor activation leads to synergistic effects on weight loss, fat metabolism, and cardiometabolic health.
• Designed as a glucagon analog rather than an oxyntomodulin mimic, offering a distinct pharmacological profile.

Primary focus:

• Weight loss and obesity management.
• Fat reduction, particularly visceral fat.
• Improvement in metabolic parameters and cardiovascular health.
• Potential benefits in non-alcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH).

---

🔹 Oral Dosage

• Not applicable; poor oral bioavailability.

---

🔹 Injectable / Subcutaneous Dosage (most common) Range:

• 0.6 mg to 4.8 mg subcutaneously once weekly.
• Doses are up-titrated to minimize gastrointestinal side effects.
• 6.0 mg is the maximum dose investigated in clinical trials.

Rationale: Subcutaneous administration allows for once-weekly dosing with sustained receptor engagement.

---

🔹 Cycle Length

• 46 weeks in pivotal Phase 2 trials.
• Ongoing Phase 3 trials with extended durations to assess long-term efficacy and safety.

---

🔹 Optimal Dosing Window

• Administer on the same day each week, preferably in the morning.
• Consistent weekly dosing enhances adherence and efficacy.

---

✅ Educational Integration Example Example protocol: 2.4 mg subcutaneously once weekly for 12 weeks. Paired with: Lifestyle modifications including dietary changes and physical activity. Rationale: Supports weight loss and metabolic health in conjunction with behavioral interventions.

---

🔹 Stacking Strategy (Educational / Complementary) Since Survodutide targets dual metabolic pathways, stacking strategies focus on enhancing lipid metabolism, insulin sensitivity, and cardiovascular health: 🔸 Metabolic & Fat Loss Support

• Tesamorelin: Enhances GH release for fat reduction and muscle preservation.
• MOTS-c: Improves mitochondrial function and fat oxidation.
• L-Carnitine: Facilitates fatty acid transport into mitochondria for energy production.

🔸 Insulin Sensitivity & Cardiovascular Health

• Berberine: Improves insulin sensitivity and supports lipid metabolism.
• Omega-3 fatty acids: Reduce inflammation and support cardiovascular health.

Rationale: Combining Survodutide with complementary agents can enhance weight loss, metabolic function, and cardiovascular health.

---

⚠️ Safety Notes

• Gastrointestinal side effects (e.g., nausea, diarrhea) are common, especially during dose escalation.
• Monitor for signs of hypoglycemia, particularly in patients with type 2 diabetes.
• Contraindicated in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.